• Profile
Close

Comparison of the effects of linagliptin and voglibose on endothelial function in patients with type 2 diabetes and coronary artery disease: A prospective, randomized, pilot study (EFFORT)

Heart and Vessels Feb 15, 2018

Koyama T, et al. - Endothelial dysfunction contributes to poor cardiovascular prognosis in patients with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD). Herein, using reactive hyperemia-peripheral arterial tonometry (RH-PAT), the impacts of linagliptin and voglibose on endothelial function were assessed in patients with newly diagnosed T2DM and CAD. It was found that compared with voglibose, linagliptin improved endothelial function, accompanied by amelioration of glycemic, renal, and cardiometabolic parameters.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay